ADHD in Hyderabad: Not Laziness, Not Bad Parenting, Not Just Childhood — A Genuine Neurodevelopmental Condition with Effective Treatment at KIMS

What you are describing — a child who is clearly capable but cannot sustain attention, complete work, or organise himself despite apparent effort — is the hallmark presentation of ADHD, inattentive subtype. The gap between intellectual ability and academic performance, when it is not explained by learning disability or environmental factors, is one of the most reliable clinical signals of ADHD. At KIMS, the assessment combines a detailed history with validated rating scales (completed by parents and teachers) and neuropsychological testing to document the specific pattern of processing speed, working memory, and sustained attention impairment. A correct diagnosis followed by appropriate treatment (methylphenidate + CBT + school accommodations) is one of the most transformative interventions in paediatric neurology and psychiatry — it converts a child who is failing into a child who is succeeding. Please call 040-44885000.

This policy is not standard and is not supported by evidence. Methylphenidate is a prescription medication for a medical condition, not a performance-enhancing drug in the sporting sense. A student with ADHD taking methylphenidate during examinations is not gaining an unfair advantage over other students — she is compensating for a genuine neurological deficit that is reducing her ability to demonstrate her knowledge under timed conditions. The Indian board examination authorities (CBSE, ICSE, state boards) provide provisions for students with medical disabilities, including extended time. Medication during examinations is part of the standard management of ADHD and should not be withheld for examinations. At KIMS, we provide formal medical documentation of the ADHD diagnosis and treatment plan for examination authority submissions. Please call 040-44885000.

Yes — adult ADHD is as real as childhood ADHD, and diagnosis in adulthood is both possible and meaningful. DSM-5 requires that some ADHD symptoms were present before age 12 (not that they were diagnosed before age 12 — many adults can recall clear childhood patterns on structured history-taking). Adult ADHD diagnosis at KIMS uses: the ASRS (Adult ADHD Self-Report Scale) and CAARS adult scales; a clinical interview covering childhood and adult symptom history; neuropsychological testing of processing speed, working memory, and executive function; and exclusion of other conditions (thyroid disorder, sleep disorder, depression) that can mimic ADHD. Treatment of adult ADHD produces significant improvements in work performance, time management, relationship quality, and quality of life. Call 040-44885000.

The safety of methylphenidate for ADHD, used at therapeutic doses under medical supervision, is well established across decades of research involving millions of children worldwide. The most common side effects are reduced appetite (usually at lunchtime — easily managed by ensuring a good breakfast before the dose and an adequate evening meal) and mild sleep onset delay (avoided by using extended-release formulations taken in the morning only). Heart rate and blood pressure are monitored at KIMS at each review. On the addiction question: the pharmacological action of therapeutic methylphenidate in ADHD is fundamentally different from addictive drug use. Therapeutic doses produce a slow, gradual increase in prefrontal dopamine that normalises attention without producing euphoria. Untreated ADHD, paradoxically, is associated with higher rates of substance misuse than treated ADHD — because people with untreated ADHD sometimes self-medicate with nicotine, alcohol, and other substances. Treating ADHD reduces, not increases, the risk of substance problems. Please call 040-44885000 to discuss your child's specific situation.

Behavioural therapy and CBT alone are effective for mild ADHD, particularly in preschool-age children (where medication is not the first choice) and in ADHD without significant academic impairment. For a 9-year-old with significant academic impact (which sounds like your daughter's situation), the research evidence is clear: medication (methylphenidate) produces the most rapid and significant improvement in ADHD core symptoms, and the combination of medication + behavioural therapy produces better outcomes than either alone. This does not mean you must start medication immediately. At KIMS, the decision is shared with you and your daughter: we can begin with CBT and parent management training, monitor the response carefully, and add medication if the response to therapy alone is insufficient. What we want to avoid is years of undertreatment during critical learning years while your daughter's self-esteem and academic confidence erode. Please call 040-44885000 to discuss the options.